Document is current
Any future updates will be listed below
-
Authors
Rehn, Fabian
Kraemer-Schulien, Victoria
Bujnicki, Tuyen
Bannach, Oliver
Tschoepe, Diethelm
Stratmann, Bernd
Willbold, Dieter
-
Funding
Funding for this research was provided by:
Helmholtz Association (HVF0079)
Helmholz Innovation lab (DB001822)
The Michael J. Fox Foundation for Parkinson’s Research (14977, 009889)
ALS Association and from the Packard Center (19-SI-476)
Deutsche Forschungsgemeinschaft (INST 208/616-1 FUGG, INST 208/794-1 FUGG)
Forschungszentrum Jülich GmbH
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 14 August 2024
First Online: 22 August 2024
Competing interests
: BS has none to declare. DW and OB are co-founder and co-owner of attyloid GmbH, which is commercializing the sFIDA technology. This did not influence any data interpretation. All the remaining authors declare no conflict of interest.
